Sale!

MITF Gene Melanoma Cutaneous Malignant NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The MITF Gene Melanoma Cutaneous Malignant NGS Genetic DNA Test is a comprehensive genetic screening that identifies mutations in the MITF gene associated with increased risk of cutaneous malignant melanoma. This advanced next-generation sequencing test provides crucial information about inherited melanoma susceptibility, enabling proactive prevention strategies and personalized surveillance plans. The test analyzes the complete MITF gene sequence to detect pathogenic variants that significantly elevate melanoma risk. Individuals with a family history of melanoma, multiple atypical moles, or personal history of skin cancer benefit from this genetic assessment. Results help guide sun protection measures, dermatological monitoring frequency, and early detection protocols. At $500 USD, this test offers valuable insights for cancer prevention and personalized healthcare management. Understanding your genetic predisposition empowers informed decisions about skin health and melanoma prevention.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

MITF Gene Melanoma Cutaneous Malignant NGS Genetic DNA Test

Comprehensive Genetic Screening for Melanoma Risk Assessment

The MITF Gene Melanoma Cutaneous Malignant NGS Genetic DNA Test represents a breakthrough in personalized cancer risk assessment, specifically targeting the genetic factors associated with cutaneous malignant melanoma. This advanced diagnostic tool utilizes next-generation sequencing technology to provide comprehensive analysis of the MITF (Microphthalmia-associated Transcription Factor) gene, which plays a critical role in melanocyte development and function.

What Does This Test Measure?

This sophisticated genetic test specifically targets and analyzes the MITF gene for pathogenic variants that have been scientifically linked to increased susceptibility to cutaneous malignant melanoma. The test examines:

  • Complete MITF gene sequencing using NGS technology
  • Detection of known pathogenic mutations associated with melanoma risk
  • Identification of novel variants with potential clinical significance
  • Assessment of genetic markers that influence melanocyte behavior
  • Evaluation of inherited predisposition to skin cancer development

Who Should Consider This Test?

This genetic screening is particularly valuable for individuals who exhibit specific risk factors or clinical indications:

  • Individuals with a strong family history of melanoma in first-degree relatives
  • Patients diagnosed with multiple primary melanomas
  • Those with numerous atypical moles or dysplastic nevi
  • Individuals with early-onset melanoma (before age 50)
  • People with personal history of melanoma seeking genetic counseling
  • Family members of individuals with confirmed MITF gene mutations
  • Patients with clinical features suggestive of hereditary melanoma syndromes

Clinical Benefits and Advantages

Undergoing the MITF Gene Melanoma NGS Test provides numerous clinical benefits:

  • Early Risk Identification: Detect genetic predisposition before melanoma development
  • Personalized Prevention Strategies: Tailor sun protection and surveillance protocols
  • Family Risk Assessment: Identify at-risk relatives for proactive monitoring
  • Informed Decision Making: Guide dermatological screening frequency and intensity
  • Psychological Preparation: Reduce anxiety through knowledge and preparedness
  • Comprehensive Genetic Counseling: Professional interpretation and guidance

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our expert genetic counselors and oncologists:

  • Positive Result: Indicates presence of a pathogenic MITF mutation, requiring enhanced surveillance and preventive measures
  • Negative Result: No known pathogenic mutations detected, though continued sun protection remains important
  • Variant of Uncertain Significance: Requires ongoing monitoring as research evolves
  • Professional Guidance: All results include comprehensive genetic counseling sessions
  • Family Implications: Discussion of potential risk to relatives and recommended screening

Test Details and Pricing

Test Component Details
Test Name MITF Gene Melanoma Cutaneous Malignant NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

To ensure accurate results and comprehensive care, we require:

  • Complete clinical history of the patient undergoing testing
  • Genetic counseling session to create detailed family pedigree
  • Documentation of family members affected by melanoma
  • Discussion of test implications and potential outcomes
  • Informed consent for genetic testing procedures

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, and many more. Our network of certified genetic counselors and oncology specialists ensures consistent, high-quality care regardless of your location.

Take Control of Your Genetic Health Today

Understanding your genetic predisposition to melanoma can be life-saving. Early detection of MITF gene mutations enables proactive prevention strategies and personalized surveillance plans. Our team of expert genetic counselors and oncology specialists are ready to guide you through this important health decision.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your MITF Gene Melanoma NGS Test. Take the first step toward personalized cancer prevention and peace of mind.